Diabetes mellitus is a condition in which the pancreas no longer produces enough insulin or when cells stop responding to the insulin that is produced, so that glucose in the blood cannot be absorbed into the cells of the body. Symptoms include frequent urination, lethargy, excessive thirst, and hunger. The treatment includes changes in diet, oral medications, and in some cases, daily injections of insulin.
New diabetes risk assessment developed — Online method is first that can be used in a multi-ethnic population – A team from the University of Leicester, led by Professor Melanie Davies from the Department of Cardiovascular Sciences and Professor Kamlesh Khunti from the Department of Health Sciences, has developed an easy way for people to assess their risk of having diabetes.
Implanted glucose sensor works for more than 1 year — Bioengineers lead glucose-sensing project – Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver.
Sensor and insulin pump results in better blood-sugar control in all age groups with diabetes – Adding a continuous blood sugar level sensor to an insulin pump helps patients with type 1 diabetes achieve better blood sugar control compared to the common standard of care, multiple daily insulin injections, concludes a study published on-line today in the New England Journal of Medicine.
Study examines relationship between type of rice consumption and diabetes risk – Consuming more white rice appears to be associated with a higher risk for developing type 2 diabetes, whereas consuming more brown rice may be associated with a lower risk for the disease, revealed by researchers.
New pathway to cheap insulin — Researchers from Helmholtz Centre in Braunschweig, Germany, publish new and more efficient method to manufacture insulin – More than eight million diabetics live in Germany. Diabetes is not restricted to our prosperous society and the highest growth rates often occur in countries with aspiring economies such as in Asia.
Increased cancer risk of people with type 2 diabetes – Cancer and diabetes ? are risk factors the same for these two diseases? Or does diabetes cause processes in the body which promote the onset or growth of cancer? It is still unclear why diabetics have a higher rate of cancer than people who are not affected by this metabolic disorder.
New associations between diabetes, environmental factors found by novel Stanford analytic technique – Researchers at the Stanford University School of Medicine suggests that one should begin looking suspiciously at other aspects of life – like past exposure to certain pesticides or chemicals and even one form of vitamin E. This may lead to diabetes.
Novel artificial pancreas successfully controls blood sugar more than 24 hours — Mass. General, Boston University researchers run first clinical trial of system using 2 hormones – An artificial pancreas system that closely mimics the body’s blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients.
New form of insulin can be inhaled rather than injected — This new, quick acting insulin inhaler uses a powder (AFREZZA?) to deliver the medication. – Scientists described a new ultra-rapid acting mealtime insulin (AFREZZA?) that is orally inhaled for absorption via the lung. Because the insulin is absorbed so rapidly, AFREZZA’s profile closely mimics the normal early insulin response seen in healthy individuals.
Hemoglobin A1c outperforms fasting glucose for risk prediction – Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at risk for clinical outcomes than the commonly used measurement of fasting glucose, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health.
FDA Drug Safety Communication: Ongoing review of Avandia (rosiglitazone) and cardiovascular safety – The U.S. Food and Drug Administration (FDA) is reviewing data, submitted in August 2009, from a large, long-term clinical study on possible risks with the diabetes drug, Avandia (rosiglitazone).
Stress raises risk of mental decline in older diabetics, study shows — Stress raises the risk of memory loss and cognitive decline among older people with diabetes, research suggests. – Researchers at the University of Edinburgh studied more than 900 men and women aged between 60 and 75 with type-2 diabetes, which tends to be common after the age of 40.
